Kaneko, Y., Nimmerjahn, F
Earlier-phase studies indicated that the drug may help reduce liver fat in people with obesity, potentially slowing the progression of NAFLD
Research suggests it may promote blood vessel formation and enhance healing processes, though human clinical data remain limited
Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis
Your dedicated healthcare provider will: Assess your medical history and goals Determine if a compounded GLP-1 medication is appropriate for you Offer nutritional guidance and lifestyle coaching Monitor your progress and adjust your plan as needed This continuous care model helps ensure that youre not alone on your path to better health
Binders work within the digestive tract to attach to these compounds at this stage, helping reduce the likelihood of reabsorption and supporting their removal